| | | | News Headlines
|
Purdue Researcher Invents Molecule that Stops SARS
18 November 2008
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
|
|
|
|
Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
14 November 2008
The Company’s RNAissance genes were used to shed light on the mechanisms that ensure that each daughter cell receives a full complement of genetic material when cells divide.
|
|
|
|
GENEART Concludes Project to Complete the National Institutes of Health's Mammalian Gene Collection
12 November 2008
For the project GENEART synthesized approximately 2,400 genes and 1,500 gene variants with an order volume of about USD 6M.
|
|
|
|
WuXi PharmaTech Signs new Collaboration Agreement with Pfizer
11 November 2008
WuXi in partnership with Pfizer will establish ADME assays to provide in vitro screening services on compounds WuXi synthesizes for Pfizer.
|
|
|
|
Geron Scientists and Collaborators Demonstrate TAT2 Enhances Antiviral Function of Immune Cells From HIV+ Donors
10 November 2008
Geron Corporation announced the publication of preclinical data on TAT2, a small molecule telomerase activator.
|
|
|
|
AltheaDx to Offer the DxS K-RAS Test for Clinical Studies
04 November 2008
DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials.
|
|
|
|
Cancer Requires Support From Immune System to Develop, UT Southwestern Researchers Report
30 October 2008
Tumors that grow around nerves in a rare genetic disease need cooperation from cells from the immune system in order to grow, reports a team of scientists, including researchers from UT Southwestern Medical Center.
|
|
|
|
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
30 October 2008
Sequenom, Inc. announced that it has licensed from Xenomics, Inc. exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed using fetal nucleic acids found in maternal urine.
|
|
|
| |
| |
|